申请人:Fisons Limited
公开号:US04419352A1
公开(公告)日:1983-12-06
There are described compounds of formula I, ##STR1## in which an adjacent pair of R.sub.5, R.sub.6, R.sub.7 and R.sub.8 form a chain --CZC(G.sub.1).dbd.(G.sub.2)--Z--, R.sub.4, R.sub.9 and the remainder of R.sub.5, R.sub.6, R.sub.7 and R.sub.8, which may be the same or different, each represent hydrogen, alkyl, halogen, alkenyl, --NO.sub.2, --NR.sub.1 R.sub.2, --OR.sub.3, --S(O).sub.n R.sub.3 ; or alkyl substituted by hydroxy, amino, alkoxy or carbonyl oxygen, n is 0, 1 or 2, R.sub.1 and R.sub.2, which may be the same or different, each represent hydrogen, alkyl, --CONHR.sub.3, phenyl or phenyl substituted by alkyl or halogen, or R.sub.1 and R.sub.2 together with the nitrogen atom to which they are attached form a 5 or 6 membered heterocyclic ring, R.sub.3 represents hydrogen, alkyl, alkenyl or phenyl, one of G.sub.1 and G.sub.2 is hydrogen and the other is a group E, each E, which may be the same or different, is --COOH, a 5-tetrazolyl group, or a carboxamidotetrazole group, each Z, which may be the same or different, is oxygen or sulphur, and one or two of the atoms, a, b, c and d are nitrogen atoms and the remainder are carbon atoms, R.sup.9 having no significance when two of a, b, c and d are nitrogen, (with certain exclusions) and pharmaceutically acceptable derivatives thereof. There are also described methods for making the compounds and pharmaceutical, e.g. anti-allergic, compositions and mixtures containing them.
本文描述了I式化合物,其中相邻的R.sub.5、R.sub.6、R.sub.7和R.sub.8形成链--CZC(G.sub.1).dbd.(G.sub.2)--Z--,R.sub.4、R.sub.9和R.sub.5、R.sub.6、R.sub.7和R.sub.8的其余部分,可以相同或不同,分别表示氢、烷基、卤素、烯基、--NO.sub.2、--NR.sub.1R.sub.2、--OR.sub.3、--S(O).sub.nR.sub.3;或者被羟基、氨基、烷氧基或羰基氧代替的烷基,其中n为0、1或2,R.sub.1和R.sub.2可以相同或不同,分别表示氢、烷基、--CONHR.sub.3、苯基或被烷基或卤素取代的苯基,或者R.sub.1和R.sub.2与它们附着的氮原子一起形成5或6元杂环环,R.sub.3表示氢、烷基、烯基或苯基,G.sub.1和G.sub.2中的一个是氢,另一个是E基团,每个E基团可以相同或不同,分别为--COOH、5-四唑基团或羧酰基四唑基团,每个Z可以相同或不同,分别为氧或硫,其中a、b、c和d中有一个或两个是氮原子,其余是碳原子,当a、b、c和d中有两个是氮原子时,R.sup.9没有意义(有一定的排除),以及其药学上可接受的衍生物。还描述了制备这些化合物的方法以及含有它们的药物,例如抗过敏的组合物和制剂。